Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the A Reliable Prognostic Marker for Liver Dysfunction in Covid-19 Infection
Amir Anushiravani
Amir Anushiravani

Associate Professor of Gastroenterology and Hepatology

Department Internal Medicine

School of Medicine

Digestive Diseases Research Center

Tehran University of Medical Sciences

Related Documents
1. A Reliable Prognostic Marker for Liver Dysfunction in Covid-19 Infection, Middle East Journal of Digestive Diseases (2021)
All Documents
1. Association Between Oxidative Stress and Liver Fibrosis Severity in Non-Alcoholic Fatty Liver Disease: Insights From the Pro-Oxidant Antioxidant Balance Method in a Population From Tehran and Mashhad, Iran, Frontiers in Medicine (2025)
2. Caffeine Supplement, Inflammation, and Hepatic Function in Cirrhotic Patients: A Randomized, Placebo- Controlled, Clinical Trial, Heliyon (2025)
3. Response Rate to Treatment of Achalasia Patients With Thyroid Disorders Versus Euthyroid Patients: A Cross-Sectional Study in Iran, JGH Open (2025)
4. Burden of Disease Scenarios for 204 Countries and Territories, 2022–2050: A Forecasting Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
5. Carbonized Aerogel/Zno-Based Dispersive Solid Phase Extraction of Daclatasvir and Sofosbuvir From Biological Samples Prior to Liquid Chromatography–Tandem Mass Spectrometry, Journal of Pharmaceutical and Biomedical Analysis (2024)
6. Causes of Colectomy in Patients With Ulcerative Colitis: Findings From an Iranian National Registry, Archives of Iranian Medicine (2024)
7. Causes of Colectomy in Patients With Ulcerative Colitis: Findings From an Iranian National Registry, Archives of Iranian Medicine (2024)
8. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (Ircc), Archives of Iranian medicine (2024)
9. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (Ircc), Archives of Iranian Medicine (2024)
10. Efficacy of Methotrexate and Anti-Tnf Combination Therapy in Adults With Refractory Crohn’S Disease, Middle East Journal of Digestive Diseases (2024)
11. Genetic and Lifestyle Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Relationship With Premature Coronary Artery Disease: A Study on the Pars Cohort, Archives of Iranian medicine (2024)
12. Global Burden and Strength of Evidence for 88 Risk Factors in 204 Countries and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
13. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
14. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
15. Investigating the Association Between the Tissue Expression of Mirna-101, Jak2/Stat3 With Tnf-Α, Il-6, Il-1Β, and Il-10 Cytokines in the Ulcerative Colitis Patients, Immunity# Inflammation and Disease (2024)
16. Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease Among an Iranian Adult Population With Ethnic and Genetic Diversity: Results of the Polyiran-Liver Study, Middle East Journal of Digestive Diseases (2024)
17. Prevalence and Correlates of Probable Nonalcoholic Steatohepatitis (Nash) in Pars Cohort Study, Archives of Iranian Medicine (2024)
18. The Association Between Anthropometric Indices and Ischemic Heart Disease: A Large-Scale Cross-Sectional Study on the Iranian Population, Scientific Reports (2024)
19. Trends and Levels of the Global, Regional, and National Burden of Appendicitis Between 1990 and 2021: Findings From the Global Burden of Disease Study 2021, The Lancet Gastroenterology and Hepatology (2024)
20. A Form of Metabolic-Associated Fatty Liver Disease Associated With a Novel Lipa Variant, Archives of Iranian Medicine (2023)
21. Comparison of Disease Phenotype and Course Among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East, Archives of Iranian Medicine (2023)
22. Iranian Consensus Guideline for Pharmacotherapy With Biologics and Small Molecules Drugs in Adults With Inflammatory Bowel Diseases, Middle East Journal of Digestive Diseases (2023)
23. Liver Fibrosis in Pars Cohort Study: A Large-Scale Study on the Prevalence and Correlated Factors, Arab Journal of Gastroenterology (2023)
24. Multicenter Validation of Fib-6 As a Novel Machine Learning Non-Invasive Score to Rule Out Liver Cirrhosis in Biopsy-Proven Mafld, European Journal of Gastroenterology and Hepatology (2023)
25. The Critical Role of Circular Rnas in Drug Resistance in Gastrointestinal Cancers, Medical Oncology (2023)
26. The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the Covid-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019, The Lancet (2023)
27. The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the Covid-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019, The Lancet (2023)
28. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases, Inflammatory Bowel Diseases (2022)
29. Evaluation of the Effect of Sofosbuvir and Daclatasvir in Hospitalized Covid-19 Patients: A Randomized Double-Blind Clinical Trial (Discover), Journal of Antimicrobial Chemotherapy (2022)
30. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
31. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
32. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
33. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
34. Original Article, Cell Journal (2022)
35. Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: Comparison With Household Members and the Role of Ibd Medications, Archives of Iranian Medicine (2022)
36. Susceptibility of Patients With Inflammatory Bowel Disease to Covid-19 Compared With Their Households, Middle East Journal of Digestive Diseases (2022)
37. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
38. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
39. A Reliable Prognostic Marker for Liver Dysfunction in Covid-19 Infection, Middle East Journal of Digestive Diseases (2021)
40. Comparison of Treatment Response in Different Types of Achalasia: A Long-Term Study, Middle East Journal of Digestive Diseases (2021)
41. Efficacy and Safety of Tofacitinib for Treatment of Moderate to Severe Active Ulcerative Colitis: First Report From Iran, Archives of Iranian Medicine (2021)
42. Erratum: Effectiveness of Polypill for Prevention of Cardiovascular Disease (Polypars): Protocol of a Randomized Controlled Trial (Archives of Iranian Medicine (2020) 23:8 (548-556) Doi: 10.34172/Aim.2020.58), Archives of Iranian Medicine (2021)
43. Fatty Liver in Covid-19: A Risk Factor or a Common Receptor?, Archives of Iranian Medicine (2021)
44. Investigating the Relationship Between the Long-Term Exposure to Air Pollution and the Frequency of Depression in Shiraz During 2010-2017, Environmental Health Engineering and Management (2021)
45. Long-Term Efficacy of Combined Treatment in Patients With Idiopathic Achalasia, Middle East Journal of Digestive Diseases (2021)
46. Nomenclature and Definition of Metabolic-Associated Fatty Liver Disease: A Consensus From the Middle East and North Africa, The Lancet Gastroenterology and Hepatology (2021)
47. Safety and Efficacy of Graded Gradual Pneumatic Balloon Dilation in Idiopathic Achalasia Patients: A 24- Year Single-Center Experience, Archives of Iranian Medicine (2021)
48. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
49. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
50. The Use of Apache Ii Scoring System for Predicting Clinical Outcome of Patients Admitted to the Intensive Care Unit: A Report From a Resource-Limited Center, Shiraz E Medical Journal (2021)
51. A Supporting System for Management of Patients With Inflammatory Bowel Disease During Covid-19 Outbreak: Iranian Experience-Study Protocol, Middle East Journal of Digestive Diseases (2020)
52. Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Hospitalized Patients With Covid-19 and Cancer History: A Propensity Score-Matched Study, Infectious Agents and Cancer (2020)
53. Effectiveness of Polypill for Prevention of Cardiovascular Disease (Polypars): Protocol of a Randomized Controlled Trial, Archives of Iranian Medicine (2020)
54. Efficacy of Anti-Tnf Therapy for the Treatment of Patients With Moderate-To-Severe Inflammatory Bowel Disease; a First Iranian Report, Middle East Journal of Digestive Diseases (2020)
55. Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? a Double-Blind Placebo-Controlled Clinical Trial, Journal of Clinical Psychopharmacology (2020)
56. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
57. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
58. Sars-Cov-2; What We Know so Far, Archives of Iranian Medicine (2020)
59. Sofosbuvir and Daclatasvir Compared With Standard of Care in the Treatment of Patients Admitted to Hospital With Moderate or Severe Coronavirus Infection (Covid-19): A Randomized Controlled Trial, Journal of Antimicrobial Chemotherapy (2020)
60. The Global, Regional, and National Burden of Cirrhosis by Cause in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
61. The Global, Regional, and National Burden of Inflammatory Bowel Disease in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2020)
62. The Necessary Gastroenterology and Hepatology Workforce in Iran, Govaresh (2020)
63. Burden of Liver Diseases: A Review From Iran, Middle East Journal of Digestive Diseases (2019)
64. The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density, Risk Management and Healthcare Policy (2019)
65. Treatment Options for Nonalcoholic Fatty Liver Disease: A Double-Blinded Randomized Placebo-Controlled Trial, European Journal of Gastroenterology and Hepatology (2019)
66. Angry Bird's Revenge: Hepatic Abscesses Secondary to Colonic Perforation, Acta Medica Iranica (2018)
67. Assessing the Performance of a Medical Intensive Care Unit: A 5-Year Single-Center Experience, Indian Journal of Critical Care Medicine (2017)
68. Pars Cohort Study of Non-Communicable Diseases in Iran: Protocol and Preliminary Results, International Journal of Public Health (2017)